Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Clinical trial NCT00003731 · COMPLETED
Trial details
- NCT number
- NCT00003731
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-12-01
- Primary completion
- 2001-01-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.